Management of retroperitoneal recurrences. Seminoma and nonseminoma.
Management of retroperitoneal recurrent tumor remains a great challenge. Accurate radiographic and clinical restaging and careful consultation with prior treating physicians can provide valuable insights into the history of each patient's disease. This, in turn, helps with choice of incision and exposure requirements. The surgeon must be prepared for all contingencies in the belly and chest, including vascular resections. When this is done, nearly 75% of patients can be rendered free of disease.
Department of Urology, Indiana University School of Medicine, Indianapolis.
J P
JP
Donohue
R S
RS
Foster
D000970:Antineoplastic Agents / Q000627:therapeutic use; D018237:Germinoma / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery*; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods*; D008297:Male; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery*; D018239:Seminoma / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery*; D013736:Testicular Neoplasms / Q000473:pathology*
D000970:Antineoplastic Agents